Skip navigation

Introduction to Drug Discovery – From Idea to Clinical Candidate

09:00-17:00

Location:
The Cambridge Building, Babraham Research Campus, Cambridge CB22 3AT
Date:
19 November 2018
 

Introduction to Drug Discovery – From Idea to Clinical Candidate

Audience

Those wanting to gain a comprehensive picture of the science and processes underpinning today’s drug discovery. Covering, step-by-step, the way in which discovery projects are systematically moved from initial ideas through the several stages required to generate potential drugs worthy of entering the clinic. Typical attendees include science-based professionals: biologists, molecular biologists, chemists, preclinical development scientists, informaticians, patent attorneys, project managers and general managers.


Duration

A one day course.

Objectives

The course is a ‘one-stop-shop’ outlining the major scientific tools of drug discovery, namely:

Drug Discovery Biology

ADMET/PK/PD

Medicinal Chemistry

Informatics/Virtual technologies.

and how these contributions are phased over time and integrated to generate a drug suitable for clinical trials. Focus is on small molecule drugs with comparisons made with biologics.  

Based on real-world experience and practical realities, attendees travel step-by-step along the typical path.

Initiating Idea -> Drug Target Protein Selection -> Lead Identification -> Clinical Candidate Nomination.

Essential related topics including:

Drug discovery technology platforms

Drug structural and functional quality attributes.

Project management tools-Target Product Profile (TPP) use.

Key technology and infrastructure requirements are also covered in the course.

Cost

One Nucleus Gold: £357 + VAT

One Nucleus Silver: £433.50 + VAT

Non-Member: £510 + VAT

Title: Introduction to Drug Discovery – From Idea to Clinical Candidate
Start: 2018-11-19 09:00:00Z
End: 2018-11-19 17:00:00Z